Ulteriori informazioni
The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products ("products from cells"), primarily monoclonals, cytokines, recombinant glycoproteins, and, increasingly, vaccines, dominate the biopharmaceutical industry. Moreover, a small number of products consisting of in vitro cultivated cells ("cells as product") for regenerative medicine have also been introduced in the market. Their efficient production requires comprehensive knowledge of biological as well as biochemical mammalian cell culture fundamentals (e.g., cell characteristics and metabolism, cell line establishment, culture medium optimization) and related engineering principles (e.g., bioreactor design, process scale-up and optimization). In addition, new developments focusing on cell line development, animal-free c- ture media, disposables and the implications of changing processes (multi-purpo- facilities) have to be taken into account. While a number of excellent books treating the basic methods and applications of mammalian cell culture technology have been published, only little attention has been afforded to their engineering aspects. The aim of this book is to make a contribution to closing this gap; it particularly focuses on the interactions between biological and biochemical and engineering principles in processes derived from cell cultures. It is not intended to give a c- prehensive overview of the literature. This has been done extensively elsewhere.
Sommario
Mammalian Cells.- Mammalian Cell Culture Technology: An Emerging Field.- Characteristics of Mammalian Cells and Requirements for Cultivation.- Bioreactors for Mammalian Cells: General Overview.- Special Engineering Aspects.- Bioreactor Design and Scale-Up.- Special Applications.- Insect Cell-Based Recombinant Protein Production.- Bioreactors for Bioartificial Organs.- Plant Cell-Based Bioprocessing.
Info autore
Priv.-Doz. Dr.-Ing. Ralf Pörtner, geb. 1958 in Melle. 1978-1984 Studium der Chemietechnik in Dortmund. 1989 Promotion Uni Dortmund, Mechanische Verfahrenstechnik. 1989-1990 Post-Doc Uni Tsukuba, Japan. Seit 1990 Oberingenieur und Leiter Arbeitsgruppe Zellkulturtechnik und Tissue Engineering, TU Hamburg-Harburg, Institut für Bioprozess- und Biosystemtechnik. 2002-2007 Lehrbeauftragter HAW Hamburg. Seit 2008 Lehrbeauftragter an der FH Gießen-Friedberg. 1997 Habilitation und Ernennung zum Privatdozenten. Mitkoordinator des Forschungsschwerpunktes Regeneration, Implantate und Medizintechnik der TU Hamburg-Harburg und Sprecher der Forschungsgruppe Tissue Engineering. Studiengangkoordinator Bioverfahrenstechnik. Etwa 60 referierte Arbeiten sowie über 120 Tagungsbeiträge zu den Themen Zellkulturtechnik, Steuerung von Bioreaktoren, Tissue Engineering.
Riassunto
The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products (“products from cells”), primarily monoclonals, cytokines, recombinant glycoproteins, and, increasingly, vaccines, dominate the biopharmaceutical industry. Moreover, a small number of products consisting of in vitro cultivated cells (“cells as product”) for regenerative medicine have also been introduced in the market. Their efficient production requires comprehensive knowledge of biological as well as biochemical mammalian cell culture fundamentals (e.g., cell characteristics and metabolism, cell line establishment, culture medium optimization) and related engineering principles (e.g., bioreactor design, process scale-up and optimization). In addition, new developments focusing on cell line development, animal-free c- ture media, disposables and the implications of changing processes (multi-purpo- facilities) have to be taken into account. While a number of excellent books treating the basic methods and applications of mammalian cell culture technology have been published, only little attention has been afforded to their engineering aspects. The aim of this book is to make a contribution to closing this gap; it particularly focuses on the interactions between biological and biochemical and engineering principles in processes derived from cell cultures. It is not intended to give a c- prehensive overview of the literature. This has been done extensively elsewhere.
